UAMY lost $0.06 per share versus the expected $0.01 loss, and sales were $10.1 million versus $16.38 million expected. Sales and antimony volumes rose from a year earlier, but UAMY also withdrew its full-year forecast, leaving the report unfavorable overall.
The missed estimates make it harder to count on the company's previously stated sales range. Sales and antimony shipments rose from a year earlier, but those gains did not prevent the shortfall or the withdrawal of its full-year forecast.
Follow United States Antimony Corp. (UAMY) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for UAMY